Skip to main content
SpringerLink
Log in

REMS lack data, according to US Inspector General

  • Review
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Department of Health and Human Services. FDA LACKS COMPREHENSIVE DATA TO DETERMINE WHETHER RISK EVALUATION AND MITIGATION STRATEGIES IMPROVE DRUG SAFETY. Internet Document : [38 pages], 1 Feb 2013. Available from: URL: https://oig.hhs.gov/oei/reports/oei-04-11-00510.pdf

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

REMS lack data, according to US Inspector General. Reactions Weekly 1441, 4 (2013). https://doi.org/10.1007/s40278-013-1606-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-1606-3

Search

Navigation